GlobalData’s clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013” provides data on the Pulmonary Arterial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Arterial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Pulmonary Arterial Hypertension 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by BRIC Nations 15

Clinical Trials by G7 Nations 16

Clinical Trials in G7 Nations by Trial Status 17

Clinical Trials by E7 Nations 18

Clinical Trials in E7 Nations by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Unaccomplished Trials of Pulmonary Arterial Hypertension 23

Subjects Recruited Over a Period of Time 28

Prominent Sponsors 29

Top Companies Participating in Pulmonary Arterial Hypertension Therapeutics Clinical Trials 31

Prominent Drug Comparison 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Actelion Ltd 34

Clinical Trial Overview of Actelion Ltd 34

United Therapeutics Corporation 38

Clinical Trial Overview of United Therapeutics Corporation 38

Pfizer Inc. 41

Clinical Trial Overview of Pfizer Inc. 41

Gilead Sciences, Inc. 44

Clinical Trial Overview of Gilead Sciences, Inc. 44

Bayer AG 45

Clinical Trial Overview of Bayer AG 45

Novartis AG 46

Clinical Trial Overview of Novartis AG 46

GlaxoSmithKline plc 47

Clinical Trial Overview of GlaxoSmithKline plc 47

Lung Rx, LLC 48

Clinical Trial Overview of Lung Rx, LLC 48

Eli Lilly and Company 49

Clinical Trial Overview of Eli Lilly and Company 49

Aires Pharmaceuticals, Inc. 50

Clinical Trial Overview of Aires Pharmaceuticals, Inc. 50

Clinical Trial Overview of Top Institutes / Government 51

Keio University 51

Clinical Trial Overview of Keio University 51

The Cleveland Clinic 52

Clinical Trial Overview of The Cleveland Clinic 52

Assistance Publique - Hopitaux de Paris 53

Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53

Rabin Medical Center 54

Clinical Trial Overview of Rabin Medical Center 54

University of California, Los Angeles 55

Clinical Trial Overview of University of California, Los Angeles 55

National Heart, Lung, and Blood Institute 56

Clinical Trial Overview of National Heart, Lung, and Blood Institute 56

Imperial College London 57

Clinical Trial Overview of Imperial College London 57

VU University Medical Center 58

Clinical Trial Overview of VU University Medical Center 58

National Institutes of Health Clinical Center 59

Clinical Trial Overview of National Institutes of Health Clinical Center 59

University of Zurich 60

Clinical Trial Overview of University of Zurich 60

Five Key Clinical Profiles 61

Appendix 210

Abbreviations 210

Definitions 210

Research Methodology 211

Secondary Research 211

About GlobalData 212

Contact Us 212

Disclaimer 212

Source 213

List of Tables

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2013* 12

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, BRIC Countries, 2013* 15

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, G7 Countries, 2013* 16

Pulmonary Arterial Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, E7 Countries, 2013* 18

Pulmonary Arterial Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Pulmonary Arterial Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23

Pulmonary Arterial Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24

Pulmonary Arterial Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013* 34

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2013* 38

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 41

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013* 44

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 45

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 46

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 47

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, LLC, 2013* 48

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 49

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aires Pharmaceuticals, Inc., 2013* 50

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2013* 51

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 52

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 53

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013* 54

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 55

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 56

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 57

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013* 58

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2013* 59

Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 60

List of Figures

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2013* 16

Pulmonary Arterial Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2013* 18

Pulmonary Arterial Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21

Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31

Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33

GlobalData Methodology 211